Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    March 2022
  1. KARSCHNIA P, Rejeski K, Winkelmann M, Schoberl F, et al
    Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells.
    Neurology. 2022 Mar 29. pii: WNL.0000000000200608.
    PubMed     Abstract available


    September 2021
  2. HOUILLIER C, Chabrot CM, Moles-Moreau MP, Willems L, et al
    Rituximab-Lenalidomide-Ibrutinib Combination for Relapsed/Refractory Primary CNS Lymphoma: A Case Series of the LOC Network.
    Neurology. 2021;97:628-631.
    PubMed     Abstract available


    January 2021
  3. MIRACLIN A, Sivadasan A, S R, Mannam P, et al
    Pearls and Oy-sters: Primary CNS Burkeitt's Lymphoma in Pregnancy: Management Challenges of a Rare Entity.
    Neurology. 2021 Jan 5. pii: WNL.0000000000011495.
    PubMed    


    November 2020
  4. TRISTAN SAMANIEGO DP, Garcia-Grimshaw M, Dominguez Moreno R, Garcia-Miranda FS, et al
    Pearls and Oy-sters: Non-motor seizures as presenting feature of Hodgkin Lymphoma CNS Involvement.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011238.
    PubMed    


    September 2020
  5. SEIDEL S, Pels H, Schlomer S, Kowoll A, et al
    Twenty years follow-up of a pilot/phase II-trial on the Bonn protocol for primary CNS lymphoma.
    Neurology. 2020 Sep 28. pii: WNL.0000000000010949.
    PubMed     Abstract available


    June 2020
  6. LUN R, Niznick N, Padmore R, Mack J, et al
    Clinical Reasoning: Recurrent strokes secondary to unknown vasculopathy.
    Neurology. 2020;94:e2396-e2401.
    PubMed    


    February 2020
  7. KRAUSE MA, English SW, Zalewski NL
    Clinical Reasoning: A 70-year-old man with rapid stepwise paraparesis and sensory loss.
    Neurology. 2020;94:e651-e655.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: